⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Top Analyst Reports For Visa, Coca-Cola & United Technologies

Published 10/26/2017, 03:36 AM
Updated 07/09/2023, 06:31 AM
T
-
KMB
-
KO
-
LLY
-
GD
-
ITW
-
HAL
-
COL
-
RTX
-
V
-

Thursday, October 26, 2017

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Coca-Cola (KO) and United Technologies (UTX). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Buy-rated Visa's shares have outperformed the Zacks Financial Transaction Services industry in the year-to-date period and is only marginally below rival MasterCard during this period (Visa is up +40.3% vs. +41.7% gain for MA and +32.6% for the industry). The company’s fiscal fourth-quarter earnings surpassed expectations and grew year over year.

Numerous strategic acquisitions and alliances, technology upgrades and effective marketing have paved the way for the company's long-term growth that have led to consistent revenue growth over the past several years. The Zacks analyst thinks Visa is well poised to gain from the growing electronic payment processing and strong international business.

A solid balance sheet ensures effective capital deployment. Strong earnings guidance instills confidence in the company. However, higher client incentives and forex volatility are some near-term headwinds.

(You can read the full research report on Visa here >>>).

Shares of Coca-Cola have outperformed the Zacks Soft Drinks Beverages industry since the beginning of the year, (+11.1% vs. +10.7%). Coca-Cola reported better-than-expected third-quarter 2017 results. However, Coca-Cola's total sales decreased 15%, marking the 10th consecutive quarterly decline in revenues.

Although top line needs to show sustained improvement, the Zacks analyst is encouraged by the company’s strategic efforts in making its portfolio as a total beverage company with improved marketing and innovation, focus on driving revenues by improved price/mix, digital focus, and productivity initiatives toward driving margins. Further, solid performance of Coke Zero Sugar globally (growing high single digit) is quite encouraging.

(You can read the full research report on Coca-Cola here >>>).

United Technologies’ shares have outperformed the Zacks Conglomerates sector in the year-to-date period (the stock is up +8.5% vs. the -1.2% decline for the sector). United Technologies reported solid third-quarter 2017 results driven by superior organic growth and diligent execution of operational plans.

The Zacks analyst thinks the acquisition of Rockwell Collins (NYSE:COL) will provide the company with bigger clout in the industry and increase its bargaining power as it would emerge as one of the largest global aircraft equipment manufacturers. Management further increased its guidance for 2017 on healthy growth dynamics.

However, United Technologies is exposed to market price volatility and availability risks related to raw materials, which hamper its ability to meet delivery schedules and increase operating costs. Fluctuations in foreign currency exchange rates affect its net investment in foreign subsidiaries and cause instability in cash flows. The company is also susceptible to high operating risks following the Brexit referendum.

(You can read the full research report on United Technologies here >>>).

Other noteworthy reports we are featuring today include Eli Lily (LLY), AT&T (T) and Novartis (NVS).

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Mark Vickery

Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Featured Reports

Novartis (NVS) Boosted By Cosentyx Amid Generic Competition

Per the Zacks analyst, the performance of new drugs like Cosentyx and Entresto offset the impact of genericization of Gleevec at Novartis. The approval of Kymriah also boost growth prospects.

Kimberly-Clark (NYSE:KMB) to Gain from Growth in Emerging Markets

Per the Zacks analyst, growth in emerging markets is likely to be a driving factor for Kimberly-Clark in the long run. However, higher commodity costs due to inflationary pressure is a concern.

Strong Drilling & Evaluation Margins Boost Halliburton (NYSE:HAL)

The Zacks analyst believes that solid execution allowed Halliburton to improve profitability at its Drilling and Evaluation unit but is concerned about pricing pressure in the international market.

Postpaid, Prepaid Wireless Subscriber Gain Boosts Sprint (S)

As per the Zacks analyst, Sprint's lucrative unlimited data plans, promotional offers in both postpaid and prepaid plans have paid off, in terms of the huge subscriber gain in the reported quarter.

Higher Premiums Aid Travelers (TRV), Catastrophe Loss Ails

Per the Zacks analyst, increasing premiums will continue to boost Travelers' earnings, thereby resulting in the company's overall growth.

Illinois Tool (ITW) to Gain from Segmental Sales, Ups View

Per the Zacks analyst, Illinois Tool Works (NYSE:ITW) is poised to gain from healthy growth in segmental business and enterprise strategies.

eviCore Deal Aids Express Scripts (ESRX) Amid Anthem Loss

The Zacks analyst is bullish on Express Scripts $3.6 billion deal to buy eviCore.

New Upgrades

Las Vegas Sands (LVS) Banks on Investments, Diversification

Per the Zacks analyst, Las Vegas Sands' planned investment in new capital projects in Macao and higher revenues from The Parisian Macao will aid growth. Revenue diversification efforts also bode well.

Lilly's (LLY) New Drugs Drive Sales, Elanco Sale Move Wise

Strong uptake trends of Lilly's new products led it to increase its 2017 sales outlook twice this year. Per the Zacks analyst, the decision to sell/spin-off the Elanco Animal Health unit is prudent.

Positive Budget, Jet Sales Growth Aid General Dynamics (NYSE:GD)

Per the Zacks analyst, the favorable defense budget scenario in the United States at present will boost General Dynamics' growth. Also, solid jet sales growth at Gulfstream business buoys optimism.

New Downgrades

Wireless Competition, Cord-Cutting Weighs on AT&T (T)

As per the Zacks analyst, AT&T lost video subscribers due to the increasing competition from online video streaming service providers. There was a 44.8% y-o-y fall in the postpaid wireless users .

Arconic (ARNC) Hurt by Hefty LIFO Charges, Pricing Woes

Per the Zacks analyst, Arconic faces earnings headwind from sizable charges related to LIFO (last-in, first-out) method of accounting. It is also exposed to pricing pressure in GRP and EPS segments.

Waning Instrument Sales, Margin Woe Hurt Abaxis (ABAX) in Q2

The Zacks analyst is concerned about Abaxis' steady underperformance related to worldwide instrument sales. Also, escalating operating expenses are putting pressure on bottom line.



Visa Inc. (NYSE:V): Free Stock Analysis Report

United Technologies Corporation (NYSE:UTX): Free Stock Analysis Report

AT&T Inc. (NYSE:T): Free Stock Analysis Report

Novartis AG (NVS): Free Stock Analysis Report

Eli Lilly and Company (NYSE:LLY): Free Stock Analysis Report

Coca-Cola Company (The) (NYSE:KO): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.